-
Cadent announces FDA Clearance of IND of CAD-9303 for Schizophrenia
- March 11, 2020
- Posted by: PharmaScroll
- Category:
No Comments -
Recent MS survey, sponsored by Celgene, highlights useful patient insights
- October 16, 2018
- Posted by: PharmaScroll
- Category:
-
Spectramax light therapy can be a potential treatment for Parkinson’s disease
- October 14, 2018
- Posted by: PharmaScroll
- Category:
-
Brain antioxidant levels can detect progression of Alzheimer’s Disease, study states
- October 14, 2018
- Posted by: PharmaScroll
- Category:
-
FDA approves Galcanezumab (Emgality) for Preventive Migraine Treatment
- October 8, 2018
- Posted by: PharmaScroll
- Category:
-
Smartphones can be used to detect Parkinson’s symptoms early, research says
- October 8, 2018
- Posted by: PharmaScroll
- Category:
-
Teva Announces AJOVY™ (fremanezumab) approval in the US market
- September 17, 2018
- Posted by: PharmaScroll
- Category:
-
Further evidence generated for Neurofilament light chain as MS biomarker
- September 7, 2018
- Posted by: PharmaScroll
- Category:
-
Xenon includes Phase 3 Ready molecule in pipeline for Epilepsy
- September 7, 2018
- Posted by: PharmaScroll
- Category:
-
Ibudilast shows benefits on slowing brain shrinkage in the latest trial results
- September 6, 2018
- Posted by: PharmaScroll
- Category: